MARATTO

preprint

Overview and definitions on lung cancer diagnosis

Abstract

According to the World Health Organization (WHO), lung cancer has been the most common cancer in the world for several decades. Thus, the use of imaging modalities is of great importance in the follow up of this disease evolution according to time. This paper gives an overview of the main existing anatomic criteria used over the time for response evaluation in lung tumor. In addition, this paper summarizes the concepts of the Response Evaluation Criteria in Solid Tumor (RECIST), revised RECIST, and the World Health Organization (WHO) guidelines. Moreover, the correlation between the various set of criteria is presented and the advantages and the shortcomings of each one are highlighted. Further, the usefulness of these guidelines for the image processing community is also studied. We aim by this paper helping the oncology community giving the appropriate therapy procedure, forecast whether a treatment is efficacious enough to be utilized on a larger scale and provide a more efficient care for the patient.

Research topics

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Medical Imaging Techniques and Applications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1109/mecbme.2018.8402427

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.